{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-21-049869","form_type":"8-K","ticker":"TMCI","cik":"0001630627","company_name":"TREACE MEDICAL CONCEPTS, INC.","filed_at":"2021-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.395720+00:00","generated_at":"2026-06-28T23:26:49.879844+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Treace Medical Concepts appoints Betsy Hanna and Deepti Jain to Board of Directors","bullets":["Appointments effective October 1, 2021; Hanna as Class II director (term to 2023), Jain as Class I (term to 2022).","Hanna to serve on Compensation and NCG Committees; Jain on Audit and NCG Committees.","Hanna is President/CEO of Clinical Genomics, former J&J Vision Care VP; MBA from Harvard.","Jain was President of IngenioRX (Anthem), COO of Pharmacy Solutions; MBA from Baruch College.","Both determined independent under Nasdaq rules; no related-party transactions disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-21-049869","json":"https://secwatch.observer/filing/0001564590-21-049869.json","markdown":"https://secwatch.observer/filing/0001564590-21-049869.md","text":"https://secwatch.observer/filing/0001564590-21-049869.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630627/000156459021049869/0001564590-21-049869-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630627/000156459021049869/tmci-8k_20210930.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T23:26:49.879844+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"690e3d3a96","claim":"Betsy Hanna was appointed as director at TREACE MEDICAL CONCEPTS, INC..","evidence_excerpt":"appointed Betsy Hanna and Deepti Jain to the Company’s Board effective October 1, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630627/000156459021049869/0001564590-21-049869-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"},{"claim_id":"7bde55c915","claim":"Deepti Jain was appointed as director at TREACE MEDICAL CONCEPTS, INC..","evidence_excerpt":"appointed Betsy Hanna and Deepti Jain to the Company’s Board effective October 1, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630627/000156459021049869/0001564590-21-049869-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}